Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
Clinical trial NCT05249114 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05249114
- Sponsor
- Providence Health & Services
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-28
- Primary completion
- 2027-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.